Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

O
Obach V. - THE GENOTYPE BC OF THE VNTR POLIMORPHISM OF THE PLATELET GLYCOPROTEIN IB-ALPHA IS RELATED TO ASPIRIN TREATMENT FAILURE IN PATIENTS WITH ISCHEMIC STROKE
Obayashi S. - MOLECULAR AND FUNCTIONAL DIVERSITY OF SNAKE VENOM VEGFS
Obergan T.Y. - GLYCINE AND LYS-PRO-ARG-GLY: POSSIBLE MECHANISMS OF ACTION ON FIBRINOLYTIC AND ANTICOAGULANT ACTIVITY
Obergan T.Yu. - THE PREVENTION OF THROMBFORMATION UNDER INFLUENCE OF A COMPLEX PREPARATION OF PLANT ANTICOAGULANT
Oberkanins C. - REVERSE-HYBRIDIZATION-BASED GENETIC TESTING FOR THE PREDICTION OF ANTICOAGULANT DOSE REQUIREMENT
Oberle V. - EXCESS THROMBIN GENERATION IN PATIENTS AFTER ON-PUMP CARDIAC SURGERY
Obert B. - EXPRESSION AND CHARACTERISATION OF 4 ADAMTS13 MUTATIONS IDENTIFIED IN PATIENTS WITH TTP (UPSHAW-SCHULMAN SYNDROME)
O'Brien L.A. - POLYMORPHIC AND MUTAGENIC SEQUENCE CHANGES IN THE A1 AND A2 DOMAINS OF VON WILLEBRAND FACTOR (VWF) RESULT IN ALTERATIONS TO ADAMTS13 CLEAVAGE EFFICIENCY
O'Brien L. - INFLUENCE OF A GT REPEAT ELEMENT ON SHEAR STRESS-RESPONSIVENESS OF THE VWF GENE PROMOTER
Obser T. - A COMMON LARGE DELETION OF VWF IN GERMAN AND ITALIAN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE TYPE 3
Ochan A.S. - PLASMAFHERESIS (PA) INFLUENCE ON MORPHOLOGICAL STATUS OF PLATELES (PLT) AT WOMEN WITH SPONTANEOS ABORTIONS - INFLAMMATORY GENESIS
Ochi M. - PREVALENCE AND DISTRIBUTION OF DEEP VEIN THROMBOSIS IN PATIENTS WITH SYMPTOMATIC PULMONARY EMBOLISM
Ochs H.D. - ANTI-ICOS IMMUNOTHERAPY PREVENTED INHIBITORY ANTIBODY FORMATION AGAINST FACTOR VIII FOLLOWING NONVIRAL GENE TRANSFER IN HEMOPHILIA A MICE
Ockelford P. - CHARACTERISATION OF RZPI PRODUCED IN ESCHERICHIA COLI
  - LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
O'Connor M.N. - USE OF HAEMOPHILIA A ZEBRAFISH FOR SENSITIVE SCREENING AND CHARACTERISATION OF NOVEL PLATELET CANDIDATE GENES DERIVED FROM POST-GENOME STUDIES FOR PRO-THROMBOTIC FUNCTION
Odame I. - EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER
O'Donnell J. - PROCOAGULANT EFFECTS OF NEOADJUVANT CHEMORADIATION FOR OESOPHAGEAL CANCER
  - ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS
  - RECURRENCE OF THE FACTOR VIII GENE R531H MUTATION IN 13 IRISH FAMILIES: EVIDENCE FOR A FOUNDER EFFECT
O'Donnell M. - CLINICAL FACTORS INFLUENCING RETURN TO NORMAL HEMOSTASIS AFTER STOPPING WARFARIN
Oehler C. - SPECIFIC AND SENSITIVE DETECTION OF THE INHIBITION OF THE PLATELET P2Y12-RECEPTOR WITH THE PFA-100 SYSTEM USING A NEW CARTRIDGE DESIGN
Oertel K. - DETERMINATION OF PLASMA COAGULATION FACTOR XIII WITH THE NOVEL FLUOROGENIC ISOPEPTIDASE ASSAY
Oettle H. - PROSPECTIVE, RANDOMIZED OPEN TRIAL OF ENOXAPARIN IN PATIENTS WITH ADVANCED PANCREATIC CANCER UNDERGOING FIRST-LINE CHEMOTHERAPY
Oettler W.W.O. - RESULTS OF A ONE-YEAR REGISTRY OF BLEEDING COMPLICATIONS OF VITAMIN K ANTAGONIST THERAPY OUTSIDE A CONTROLLED POPULATION
Offelli P. - THROMBOPHILIA IN PATIENTS WITH CRYPTOGENETIC STROKE AND PATENT FORAMEN OVALE
Ofir K. - HIGH PROPORTION OF MATERNAL THROMBOPHILIA AMONG PREVIOUSLY UNEXPLAINED STILLBIRTH CASES
Oganova E.G. - FACTOR VON WILLEBRAND IN PATIENTS WITH METABOLIC SYNDROME
  - PROTEIN C IN PATIENTS WITH METABOLIC SYNDROME
Ogata K. - FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY
Ogata Y. - Pharmacokinetics of a mixture of FVIIa and FX in rats
Ogata K. - CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
Ogawa T. - COMPARISON OF ANTIPLATELET AND ANTITHROMBOTIC EFFECTS OF PRASUGREL AND AZD6140
  - FLOW CYTOMETRIC ANALYSIS OF VASP PHOSPHORYLATION IN PLATELETS TREATED WITH THE ACTIVE METABOLITE OF PRASUGREL, A P2Y12 ADP RECEPTOR ANTAGONIST
Oger E.J. - BODY MASS INDEX, MILD HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOEMBOLISM RISK
Oger E. - VKORC1 GENETIC POLYMORPHISM IS ASSOCIATED TO VENOUS THROMBOEMBOLISM: RESULTS FROM THE EDITH STUDY
Ogihara J. - A NOVEL FIBRINOLYTIC FACTOR ADIPOMIN REGULATES ADIPOSITY
Ogihara Y. - THE PHARMACOLOGICAL PROFILE OF DZ-697B, A NOVEL ANTI-PLATELET AGENT
Ogletree M.L. - INHIBITION OF MEASURED THROMBIN GENERATION IN HUMAN PLASMA BY APIXABAN: A PREDICTIVE MATHEMATICAL MODEL BASED ON EXPERIMENTALLY DETERMINED RATE CONSTANTS
  - CLOPIDOGREL PRODUCES DISTINCT DOSE-RESPONSE RELATIONSHIPS FOR INHIBITION OF PLATELET AGGREGATION (IPA) AND ANTITHROMBOTIC EFFICACY MEASURED IN RATS AND RABBITS
  - POTENT ANTITHROMBOTIC ACTIVITY OF APIXABAN, A DIRECT FACTOR XA INHIBITOR, WITH MINIMUM BLEEDING TIME EFFECT IN RABBIT MODELS OF ARTERIAL THROMBOSIS AND HEMOSTASIS
Ognibene A. - DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS?
Ogura H. - THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS
Oh K. - ANTIPROLIFERATIVE ACTIVITY OF YQN1, A NEWLY SYNTHESIZED INDOLEDIONE DERIVATIVE, ON PDGF-BB-STIMULATED AORTIC VASCULAR SMOOTH MUSCLE CELLS
Oh D. - CHANGES OF THE PLASMA LEVELS OF PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND ANTIHOSPHOLIPID SYNDROME
Oh S.S.Y. - CHANGES OF THE PLASMA LEVELS OF PLATELET AND ENDOTHELIAL MICROPARTICLES IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND ANTIHOSPHOLIPID SYNDROME
Oh M. - BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER?
  - BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE
Oh D. - EARLY DIAGNOSIS OF SEPTIC DISSEMINATED INTRAVASCULAR COAGULOPATHY
Oh S. - PLASMA LEVELS OF PROTHROMBIN FRAGMENT F1+2, D-DIMER, AND PROTHROMBIN TIME IN GASTRIC CANCER PATIENTS CORRELATE WITH CLINICAL STAGE AND LYMPH NODE METASTASIS
Oh D. - C936T MUTATION IN THE VEGF GENE AS AN INDEPENDENT RISK FACTOR FOR PATIENTS WITH SILENT BRAIN INFARCTION
  - GENDER-SPECIFIC ASSOCIATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR POLYMORPHISMS (VEGF -2578CA AND -634GC) AND THE RISK OF ISCHEMIC STROKE
  - ANALYSIS OF EFFECTS OF METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) AND THYMIDYLATE SYNTHASE ENHANCER REGION (TSER) POLYMORPHISMS ON HOMOCYSTEINE CONCENTRATION AND RECURRENT SPONTANEOUS ABORTION IN KOREANS
Ohkura N. - CIRCADIAN VARIATIONS IN COAGULATION AND FIBRINOLYTIC FACTORS AMONG FOUR STRAINS OF MICE
Ohlmann P. - IDENTIFICATION OF PF4 AND BETA-TG BY PROFILING AND LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY OF SUPERNATANT PEPTIDES IN STORED APHERESIS AND BUFFY-COAT PLATELET CONCENTRATES
  - EX VIVO ANTITHROMBOTIC EFFECTS OF ANTI GPVI FAB FRAGMENT IN NON-HUMAN PRIMATES WITHOUT MODIFICATION OF GPVI EXPRESSION
Ohmori T. - SILENCING OF A TARGETED PROTEIN IN IN VIVO PLATELETS USING A LENTIVIRAL VECTOR DELIVERING SHORT HAIRPIN RNA SEQUENCE
  - INDUCTION OF FACTOR VIII SPECIFIC UNRESPONSIVENESS BY INTRATHYMIC FACTOR VIII INJECTION IN MURINE HEMOPHILIA A
Ohnishi K. - DISORDERS OF COLLAGEN-INDUCED AGGREGATION OF PLATELETS FROM CATTLE AND RATS WITH CHEDIAK-HIGASHI SYNDROME
Ohsawa M. - 1,25(OH)2D3 BLOCKS TNF-INDUCED MONOCYTIC TISSUE FACTOR EXPRESSION BY INHIBITION OF TRANSCRIPTION FACTORS AP-1 AND NF-KAPPAB
Ohsugi T. - ISOFLAVONE GENISTEIN AND ITS ANALOGUES ENHANCED T-PA PRODUCING ACTIVITY OF HELA S3
Ohtomo Y. - THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS
Øie C.I. - ROLE OF LIVER SINUSOIDAL ENDOTHELIAL CELLS IN ELIMINATION OF HEPARIN
Oishi K. - CIRCADIAN VARIATIONS IN COAGULATION AND FIBRINOLYTIC FACTORS AMONG FOUR STRAINS OF MICE
Ojala M. - PLATELET INTEGRIN ALPHA2BETA1 INTERACTION WITH TYPE I COLLAGEN IS INHIBITED BY A NOVEL SYNTHETIC MOLECULE BTT-3016
Ojalvo A.G. - ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION
  - MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
Okada K. - EFFECT OF SYNTHETIC PEPTIDES DERIVED FROM STAPHYLOKINASE ON THE ACTIVATION OF PLASMINOGEN
Okada H. - ALLELIC FREQUENCY AND MINOR VARIATIONS OF THE FACTOR V R2 HAPLOTYPE IN JAPANESE POPULATION
  - EVALUATION OF LASER-INDUCED THROMBOLYSIS IN THE RAT THROMBOSIS MODELS: A PULSED GREEN LASER TECHNIQUE
  - DIFFERENTIAL DETECTION OF WILD-TYPE AND MUTANT MYH9 MRNA AND NMMHC-IIA POLYPEPTIDE REVEALS DOMINANT-NEGATIVE EFFECT IN GRANULOCYTES AND HAPLOINSUFFICIENCY IN PLATELETS IN PATIENTS WITH MYH9 DISORDERS
  - THE PROTEIN S THROMBIN SENSITIVE REGION CONTRIBUTES REGULATION OF WARFARIN TREATED DES-GAMMA-CARBOXYLATED PROTEIN S SECRETION: A STUDY OF A NOVEL SPLICE SITE MUTATION OF PROTEIN S GENE AND ITS MOLECULAR CONSEQUENCES
Okajima K. - ACTIVATED PROTEIN C INCREASES TISSUE FACTOR EXPRESSION ON HUMAN UMBILICAL ENDOTHELIAL CELL BY EPCR-DEPENDENT BUT PAR-1-INDEPENDENT MANNER
Okamoto T. - PREVALENCE OF DEEP VENOUS THROMBOSIS OR PULMONARY EMBOLISM (DVT/PE) IN PSYCHIATRY PATIENTS
  - RELATIONSHIP BETWEEN THE DIAMETER OF SOLEUS VEIN AND D-DIMER
Okamoto C. - EFFECT OF SYNTHETIC PEPTIDES DERIVED FROM STAPHYLOKINASE ON THE ACTIVATION OF PLASMINOGEN
Okamoto A. - AGE- AND GENDER-RELATED DIFFERENCES OF PLASMA PROTHROMBIN ACTIVITY LEVELS
Okamoto T. - PLASMA D-DIMER CORRELATES WITH AGE, CAROTID ARTERIAL OR THORACIC AORTIC ATHEROSCLEROSIS
Okamoto K. - THE PROGRESS AND CHARACTERISTICS OF DISSEMINATED INTRAVASCULAR COAGULATION DIAGNOSED BY NEWLY ESTABLISHED DIAGNOSTIC CRITERIA FOR CRITICALLY ILL PATIENTS
Okamoto T. - REGULATION OF PROTEIN S EXPRESSION IN HEPATOCYTES AND SINUSOIDAL ENDOTHELIAL CELLS IN RATS WITH CIRRHOSIS
  - PREVALENCE OF DEEP VENOUS THROMBOSIS IN A YEAR AFTER THE MID NIIGATA PREFECTURE EARTHQUAKE
Okamura Y. - PROLONGED HEMOSTATIC ABILITY OF POLY(ETHYLENE GLYCOL)-MODIFIED POLYMERIZED ALBUMIN PARTICLES CARRYING FIBRINOGEN-GAMMA CHAIN DODECAPEPTIDE
  - HEMOSTATIC EFFECTS OF LIPOSOMES CARRYING FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE AS A PLATELET SUBSTITUTE
  - HEMOSTATIC EFFECTS OF LIPOSOMES CARRYING FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE AND ENCAPSULATING ADENOSINE 5'-DIPHOSPHATE AS A PLATELET SUBSTITUTE
Okamura K. - REDUCTION OF ANTI-FIX INHIBITOR TITER IN A HEMOPHILIA B PATIENT WITH CONTINUOUS USE OF APCC
Okayama A. - ACTIVITIES AND POLYMORPHISMS OF ADAMTS13 IN THE JAPANESE GENERAL POPULATION
  - AGE- AND GENDER-RELATED DIFFERENCES OF PLASMA PROTHROMBIN ACTIVITY LEVELS
Okazaki E. - DIFFICULTIES IN THE TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA WITH BLEEDING SYMPTOMS
O'Keeffe D. - THE USE OF THE WARKENTIN ET AL 4T CLINICAL SCORING SYSTEM TO DETERMINE PROSPECTIVELY THE APPROPRIATENESS OF HIT ANTIBODY TESTING AT THE REGIONAL HAEMOSTASIS LABORATORY, BELFAST CITY HOSPITAL, N IRELAND
Okroj W. - DIAMOND PARTICLES OF MICROMETRIC SIZE ARE INTERNALIZED BY ENDOTHELIAL CELLS
Oktay A. - RADIOISOTOPE SYNOVECTOMY WITH RHENIUM 186 FOR TREATMENT OF HEMOPHILIC SYNOVITIS
Oku K. - THE P38 MITOGEN-ACTIVATE PROTEIN KINASE MAPK) PATHWAY MEDIATES THE INDUCTION OF TISSUE FACTOR EXPRESSION BY PHOSPHATIDYLSERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODIES WITH LUPUS ANTICOAGULANT ACTIVITY
Okumura K. - FOUR NOVEL CAUSATIVE MUTATIONS IDENTIFIED IN THE PROS1 GENE OF JAPANESE DEEP VEIN THROMBOSIS PATIENTS WITH PROTEIN S DEFICIENCY
Okumura N. - A ROLE OF SURFACE-BOUND PLASMINOGEN IN THE LIVER REGENERATION IN RAT
Okumura K. - MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
Okumura N. - MARKEDLY IMPAIRED BUT SIGNIFICANT THROMBIN-CATALYZED FIBRIN POLYMERIZATION OBSERVED AT VARIANT FIBRINOGENS AT GAMMA364ASP RESIDUE IS ARISEN FROM B-KNOB AND B-HOLE BONDING
Okuyama K. - A NOVEL FIBRINOLYTIC FACTOR ADIPOMIN REGULATES ADIPOSITY
Oláh Z. - COULD HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOSIS BE A RARE MANIFESTATION OF ANTIPHOSPHOLIPID ANTIBODY SYNDROME?
Olah Z. - LOW DOSE ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE PROPHYLAXIS OF A PATIENT WITH ACQUIRED HAEMOPHILIA AFTER UNSUCCESSFUL ERADICATION THERAPY
Oláh Z. - SUCCESSFUL IMMUNE TOLERANCE INDUCTION TREATMENT OF THERAPY-RESISTENT ACQUIRED HAEMOPHILIA WITH HIGH INHIBITOR TITER: A CASE REPORT
  - A PILOT STUDY WITH AUTOLOGOUS BONE MARROW-DERIVED STEM CELL TRANSPLANTATION (ABSCT) IN PATIENTS WITH SEVERE PERIPHERAL ARTERIAL DISORDER (SPAD)
Oldenburg J. - COMBINED FACTOR V AND FACTOR VIII DEFICIENCY: MUTATION ANALYSIS AND ETHNICAL BACKGROUND OF FIVE PATIENTS
  - FVIII CONCENTRATES OF RECOMBINANT ORIGIN SHOW A HIGHER THROMBIN SENSITIVITY THAN PLASMA-DERIVED FVIII CONCENTRATES BUT NEARLY IDENTICAL APC-MEDIATED INACTIVATION KINETICS
  - SEVEN NOVEL MISSENSE MUTATIONS IN THE VITAMIN K EPOXIDE REDUCTASE COMPLEX SUBUNIT 1 (VKORC1) CAUSE HEREDITARY COUMARIN RESISTANCE
  - D-DIMER LEVELS IN RELATION TO FACTOR V 1691 GENOTYPE AND ORAL ANTICOAGULATION. A CASE-CONTROL-STUDY OF 46 HOMOZYGOUS AND HETEROZYGOUS FACTOR V LEIDEN PATIENTS
  - D-DIMER LEVELS IN RELATION TO FACTOR V 1691 GENOTYPE AND ORAL ANTICOAGULATION. A CASE-CONTROL-STUDY OF 46 HOMOZYGOUS AND HETEROZYGOUS FACTOR V LEIDEN PATIENTS
  - LONG-TERM PHARMACOVIGILANCE UPDATE WITH A RECOMBINANT FVIII CONCENTRATE FOR THE TREATMENT OF HEMOPHILIA A
  - PHARMACOGENETICS OF ORAL ANTICOAGULATION - VKORC1-HAPLOTYPES DETERMINE THE INTER-INDIVIDUAL VARIABILITY
  - PSEUDO-HOMOZYGOUS APC RESISTANCE DUE TO COINHERITANCE OF HETEROZYGOUS FACTOR V-R506Q AND FV TYPE I DEFICIENCY
  - GENETIC BASIS OF ACQUIRED HAEMOPHILIA
  - SUCCESSFUL ANGIOGRAPHIC EMBOLIZATION OF RECURRENT ELBOW JOINT BLEEDS IN FIVE PATIENT WITH SEVERE HAEMOPHILIA A
  - HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS
  - BREAKPOINT CHARACTERIZATION IN HEMOPHILIA PATIENTS WITH LARGE DELETIONS IN THE FVIII GENE REVEALS INVOLVEMENT OF VARIOUS MUTATION MECHANISMS
  - FIVE NOVEL MUTATIONS IN F13B GENE RESULTING IN MILD FXIII DEFICIENCY
  - INFLUENCE OF PERINATAL RISK FACTORS ON THE DEVELOPMENT OF PLASMATIC COAGULATION IN EXTREMELY PRETERM INFANTS
  - IN VIVO-ASSAY FOR WARFARIN-RESISTANCE BY COEXPRESSION OF VKORC1 AND VITAMIN K-DEPENDENT COAGULATION FACTORS
  - A COMMON LARGE DELETION OF VWF IN GERMAN AND ITALIAN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE TYPE 3
  - FACTOR VIII CONCENTRATES OF RECOMBINANT ORIGIN SHOW A HIGHER SUSCEPTIBILITY TO THROMBIN PROTEOLYSIS THAN PLASMA-DERIVED CONCENTRATES BUT NEARLY IDENTICAL INACTIVATION RATES BY ACTIVATED PROTEIN C
  - VKORC1: MOLECULAR TARGET OF COUMARINS
Oliovecchio E. - HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY
Oliveira M.F.H.C. - FACTOR V INHIBITORS: DIVERSITY IN CLINICAL PRESENTATION
Oliveira S.C. - DELAYED ONSET OF LOW MOLECULAR WEIGHT HEPARIN INDUCED THROMBOCYTOPENIA TYPE II IN A CARDIAC PATIENT
Oliveira S. - DELAYED ONSET OF LOW MOLECULAR WEIGHT HEPARIN INDUCED THROMBOCYTOPENIA TYPE II IN A CARDIAC PATIENT
Oliveira L.C. - EVALUATION OF MILD HHCY IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN APOE-DEFICIENT AND NORMAL MICE
Oliveira M.H.C.F. - ACQUIRED FACTOR XIII INHIBITOR: A CASE REPORT
Oliveira N.N.C.O. - ACQUIRED FACTOR XIII INHIBITOR: A CASE REPORT
Oliveira M.H.C.F. - 807C/T POLYMORPHISM IN THE PLATELET GLYCOPROTEIN IA GENE IN PATIENTS WITH RETINAL VEIN OCCLUSION
Oliver A. - CONTRIBUTION OF C46T MUTATION IN F12 GENE TO THROMBOTIC RISK IN THROMBOPHILIC FAMILIES WITH FACTOR V LEIDEN MUTATION
Olivieri M. - VARIABILITY IN PERFORMING PLATELET AGGREGOMETRY FOR DIAGNOSIS OF INBORN DISORDERS OF PLATELET FUNCTION IN GERMANY, AUSTRIA AND SWITZERLAND
  - DIAGNOSIS AND THERAPY OF CHILDREN WITH INHERITED DEFECTS OF PLATELET FUNCTION IN GERMAN SPEAKING COUNTRIES: QUALITY PROJECT THROMKID
Olivieri O. - INCREASED ARACHIDONIC/LINOLEIC RATIO AND A POLYGENIC MODEL OF DESATURASE POLYMORPHIMS ARE ASSOCIATED WITH INCREASED RISK OF CORONARY ARTERY DISEASE
Ollieuz S. - USE OF SOLUBLE FIBRIN MONOMER (SFM) WITH DDIMER (DDI) AND THE ISTH SCORE MAY AID IN DIAGNOSIS OF DIC
Ollivier V. - MONOCYTES DOWN-REGULATE INITIAL PHASE OF COLLAGEN-INDUCED PLATELET ACTIVATION
  - INCREASED PLASMA MARKERS OF PLATELET AND PROTHROMBIN ACTIVATION IN PATIENTS WITH THORACIC ASCENDING AORTIC ANEURYSM
Olsen O.H. - FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES
Olsen E.H.N. - EFFECT OF RECOMBINANT FACTOR XIII-A ON ENDOTHELIAL BARRIER FUNCTION
Olsen J. - DETERMINATION OF TISSUE FACTOR ORIGIN USING SIRNA KNOCKDOWN APPROACH IN HUMAN PERIPHERAL BLOOD WHITE CELLS
Olsen E.H.N. - CLEARANCE OF FACTOR VIIA (FVIIA) IN THE MOUSE IS NOT AFFECTED BY ALPHA 2-MACROGLOBULIN GENE DELETION OR ACTIVE-SITE BLOCKAGE OF FVIIA
Olsen O.H. - PROBING THE ORIGINS OF ACTIVITY ENHANCEMENT IN FACTOR VIIA (FVIIA) VARIANTS BY HYDROGEN EXCHANGE MASS SPECTROMETRY (HX-MS)
Olsen K. - PHARMACOKINETIC/PHARMACODYNAMIC PROFILE OF A NOVEL APTAMER DIRECT THROMBIN INHIBITOR IN CYNOMOLGUS MONKEYS AND YORKSHIRE PIGS FOLLOWING A SINGLE IV BOLUS ADMINISTRATION
Olsen E.H.N. - COMBINED EFFECTS OF RFVIIA AND RFXIII ON CLOT FORMATION AND STABILITY IN PLASMA AND BLOOD FROM NORMAL DONORS AND FROM THROMBOCYTOPENIC PATIENTS
Olsen O.H. - COAGULATION FACTOR VIIA VARIANTS WITH REDUCED SUSCEPTIBILITY TO INHIBITION BY ANTITHROMBIN III
Olsen J. - BLOOD BORNE TISSUE FACTOR: CELLULAR LOCALIZATION AND SPECIFIC ACTIVITIES
Olsen O.H. - ACTIVATION LOOP 3 AND THE 170 LOOP INTERACT IN THE MOST ACTIVE CONFORMATION OF FACTOR VIIA
Olson K. - DISCOVERY OF A POTENT, DIRECT THROMBIN INHIBITING APTAMER
Olson S.T. - THE ANTITHROMBIN III SERINE-380 P14 HYDROXYL MAKES CRITICAL CONTRIBUTIONS TO METASTABILITY OF THE NATIVE CONFORMATION AND TO STABILIZATION OF THE HEPARIN-BOUND ACTIVATED STATE
Olsson C. - EARLY HOME THERAPY AND OUTCOME AMONG 675 PATIENTS WITH PULMONARY EMBOLISM
Olsson T. - SUBSTRATE SPECIFICITY STUDY OF CARBOXYPEPTIDASE U (TAFIA): DEVELOPMENT OF HIGHLY SELECTIVE CPU SUBSTRATES AS USEFUL TOOLS FOR ASSAY DEVELOPMENT
Olsson B. - SAFETY AND TOLERABILITY OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 IN PREVENTION OF STROKE AND OTHER THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH ATRIAL FIBRILLATION (AF)
Oltra J. - IDENTIFICATION OF DELETIONS IN WOMEN WITH FAMILY ANTECEDENTS OF SEVERE HAEMOPHILIA B BY MULTIPLE LIGATION PROBE AMPLIFICATION METHOD. COMPARISON WITH QUANTITATIVE REAL-TIME ASSAY
Ombandza E. - D-DIMER MEASUREMENT AND THROMBOPHILIA SCREENING IN THE FOLLOW-UP OF PATIENTS WITH A HISTORY OF VENOUS THROMBOEMBOLISM
O'Meara E. - COAGULATION FACTORS IX - XIII AND RISK OF FUTURE VENOUS THROMBOSIS: THE LONGITUDINAL INVESTIGATION OF THROMBOEMBOLISM ETIOLOGY (LITE)
Omori H. - THE RISK FACTORS FOR THROMBOEMBOLISM IN PATIENTS WITH MECHANICAL VALVE
  - OPTIMAL ANTICOAGULANT INTENSITY FOR JAPANESE PATIENTS WITH MECHANICAL VALVE
Omoto S. - EFFECTS OF PITAVASTATIN AND EICOSAPENTAENOIC ACID ON PLATELET-DERIVED MICROPARTICLES AND ADIPONECTIN IN HYPERLIPIDEMIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
Ondei P. - THROMBOTIC MARKERS AND MITRAL VALVE PROLAPSE IN MIGRAINE WITH AND WITHOUT AURA AT CHILDHOOD ONSET
O'Neil B.J. - MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
O'Neill S. - A NOVEL ROLE FOR CADHERIN 6 IN PLATELET FUNCTION
  - S-NITROSYLATION OF THE PLATELET INTEGRIN ALPHA IIB BETA 3
  - HOMOCYSTEINE AND ITS THIOLACTONE DERIVATIVE ACTIVATE THE PLATELET INTEGRIN ALPHA IIB BETA 3
Oney S. - DEVELOPING ANTIDOTE CONTROLLED ANTIPLATELET THERAPIES BY TARGETING THE VWF - GP IB-IX-V INTERACTION
Ong J.B. - CRYOPRECIPITATE-REMOVED PLASMA AS A SOURCE OF FACTOR IX IN THE TREATMENT OF HEMOPHILIA B
Ongini E. - NCX-6550, A NITRIC OXIDE-DONATING DERIVATIVE OF PRAVASTATIN, EXERTS ANTI-INFLAMMATORY ACTIVITY IN HYPERCHOLESTEROLEMIC MICE
Onimaru M. - VEGF FUNCTION FOR UPREGULATION OF ENDOGENOUS PLGF EXPRESSION DURING FGF-2-MEDIATED THERAPEUTIC ANGIOGENESIS
  - ROLE OF ANGIOPOIETIN(ANG)-1/TIE-2 SIGNALING PATHWAY FOR ANG-2 EXPRESSION IN VASCULAR ENDOTHELIAL CELLS
Onishi T. - REDUCTION OF ANTI-FIX INHIBITOR TITER IN A HEMOPHILIA B PATIENT WITH CONTINUOUS USE OF APCC
Ono A. - THE NON-CATALYTIC SIGNALLING FUNCTION OF PI 3-KINASE P110GAMMA PROMOTES PLATELET ACTIVATION AND THROMBUS FORMATION
  - SELECTIVE SIGNALLING ROLE FOR PI 3-KINASE P110BETA IN THROMBIN-INDUCED CLOT RETRACTION
Ono T. - ADAMTS13 AND VON WILLEBRAND FACTOR IN THE PATIENTS WITH DIC
Ono A. - HYPERGLYCAEMIA AND DYSLIPIDAEMIA ARE NOT SUFFICIENT TO INDUCE PLATELET HYPERACTIVITY IN THE DIABETIC APOLIPOPROTEIN E-/- MOUSE
Ontachi Y. - CLINICAL SIGNIFICANCE OF PLATELET-DERIVED MICROPARTICLE (PDMP) IN APS: PLASMA LEVELS OF PDMP WERE SIGNIFICANTLY ELEVATED IN APS PATIENTS WITH ARTERIAL THROMBOSES
  - PATHOPHYSIOLOGICAL MECHANISMS OF VASCULOPATHY IN SYSTEMIC SCLERODERMA (SSC): PLATELET ACTIVATION INDUCED BY APL IS ASSOCIATED WITH ARTERIAL THROMBOSES AND DIGITAL PITTING SCAR IN SSC PATIENTS
Onundarson P.T. - WARFARIN ANTICOAGULATION INTENSITY IN SPECIALIST-BASED AND IN COMPUTER -ASSISTED DOSING PRACTICE
  - PREDICTION OF PRIMARY HEMOSTATIC DEFECT TYPE AND SEVERITY WITH THE PFA-100 CLOSURE TIME
Oonishi S. - Pharmacokinetics of a mixture of FVIIa and FX in rats
Oortwijn B.D. - LIVER AND SPLEEN MACROPHAGES CONTRIBUTE TO THE CLEARANCE OF VON WILLEBRAND FACTOR AND ITS COMPLEX WITH FACTOR VIII
Oottamasathein D. - REDUCTION OF DIABETES-RELATED LIPID OXIDATIVE STRESS BY STATIN THERAPY AS MONITORED BY SERUM OXIDIZED LDL/B2GPI COMPLEX LEVELS
  - ASSOCIATION OF IGG ANTI-OXLDL/B2GPI AND B2GPI-DEPENDENT ANTI-CARDIOLIPIN (ACL) ANTIBODIES WITH VASCULAR THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS)
Opatrny L. - WARFARIN USE AND THE DECREASED RISK OF PROSTATE CANCER
Opitz B. - PROSPECTIVE, RANDOMIZED OPEN TRIAL OF ENOXAPARIN IN PATIENTS WITH ADVANCED PANCREATIC CANCER UNDERGOING FIRST-LINE CHEMOTHERAPY
Oprisoni A. - HEMOSTATIC EXPRESSION OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN
Orban T. - ALLOSTERIC REGULATION OF PROTHROMBIN ACTIVATION BY FACTOR VA
  - CONTRIBUTION OF ASP334 AND TYR335 OF FACTOR VA TO PROTHROMBINASE FUNCTION
  - IDENTIFICATION OF A BINDING SITE FOR FACTOR XA ON THE LIGHT CHAIN OF FACTOR VA
  - THE INTERACTION OF PROTHROMBIN WITH THE MEMBRANE SURFACE IS A PREREQUISITE FOR OPTIMUM EXPRESSION OF FACTOR VA COFACTOR ACTIVITY WITHIN PROTHROMBINASE
  - THE ROLE OF THE ACIDIC COOH-TERMINAL REGION OF FACTOR VA HEAVY CHAIN DURING ACTIVATION OF PROTHROMBIN BY PROTHROMBINASE
Orbe J. - THROMBIN INDUCES MMP-10 IN HUMAN ENDOTHELIAL CELLS: PATHOPHYSIOLOGICAL IMPLICATIONS IN DISSEMINATED INTRAVASCULAR COAGULATION
  - EFFECT OF AGING ON PLASMINOGEN ACTIVATOR INHIBITOR-1 EXPRESSION IN RAT TISSUES. POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND CARDIOVASCULAR RISK
  - CYTOKINE-INDUCED MONOCYTE-ENDOTHELIAL CELL INTERACTIONS: EFFECT ON PAI-1 LEVELS
Ordóñez A. - CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES
Ordoñez A. - IN VIVO EFFECTS OF HYPERTHERMIA ON THE FUNCTIONAL AND CONFORMATIONAL CHARACTERISTICS OF ANTITHROMBIN
Ordóñez A. - HEPARIN PROTECTS THE NATIVE CONFORMATION OF ANTITHROMBIN
  - ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS
Ordoñez A. - BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS
Orehova L. - THE INFLUENCE OF DIFFERENT ANTISEPTICS UPON THE IN VITRO PLATELET ACTIVITY IN PATIENTS WITH PERIODONTITIS TREATED BY AUTOLOGOUS PRP TRANSPLANTATION
Oren H. - LOW-DOSE IMMUNE TOLERANCE INDUCTION IN THE TREATMENT OF PEDIATRIC HEMOPHILIA A PATIENTS WITH FACTOR VIII INHIBITORS-TURKISH EXPERIENCE
Orf K. - GENERATION OF INTERMEDIATE AFFINITY FORMS OF 2 I DOMAIN
Orfeo T. - THROMBIN GENERATION PROFILES IN PATIENTS WITH ACUTE CORONARY SYNDROME AND STABLE CORONARY ARTERY DISEASE: A COMPUTATIONAL ANALYSIS
Origasa H. - RISK FACTOR PROFILE AND PATTERN OF USE OF MEDICATIONS IN JAPANESE PATIENTS AT A HIGH RISK OF CARDIOVASCULAR DIEASE: RESULTS FROM THE JAPAN THROMBOSIS REGISTRY FOR ATRIAL FIBRILLATION, CORONARY AND CEREBROVASCULAR DISEASE (J-TRACE)
O'Riordan W. - ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTE ISCHEMIC STROKE PATIENTS
Orje J.N. - BIOMECHANICAL PROPERTIES OF VON WILLEBRAND FACTOR BINDING TO PLATELET GLYCOPROTEIN IB RECAPITULATED BY THE DIMERIC A1 DOMAIN
  - PROTEOLYSIS-INDEPENDENT ENHANCEMENT OF ARTERIAL THROMBOSIS MEDIATED BY THROMBIN BINDING TO GLYCOPROTEIN IB AND VON WILLEBRAND FACTOR
Orlando C. - IDENTIFICATION OF TWO DE NOVO ANTITHROMBIN TYPE I MUTATIONS
Orlovic M. - INFLUENCE OF THROMBOPHILIA ON VASCULAR ACCESS SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS
  - 10-YEARS EFFICACY, SAFETY AND INHIBITORS IN ONE PLASMA-DERIVED FACTOR VIII CONCENTRATE
Orsi F.L.A. - DAPSONE TREATMENT IN STEROID-DEPENDENT OR REFRACTORY ADULT ITP PATIENTS CAN AVOID IMMEDIATE SPLENECTOMY AFTER STEROID FAILURE
Ortego M. - TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE 1 (TIMP-1) PREDICTS RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY IN END STAGE SYSTOLIC HEART FAILURE
Ortel T.L. - PLATELET AGGREGATION AND SEROTONIN ACTIVITY
Ortel T. - ADAMTS13 ACTIVITY AND AUTOANTIBODIES IN IDIOPATHIC TTP: RESULTS FROM THE SERF-TTP GROUP
  - RISK FACTORS FOR THROMBOTIC THROMBOCYTOPENIC PURPURA: RESULTS OF THE SURVEILLANCE, EPIDEMIOLOGY AND RISK FACTORS FOR TTP (SERF-TTP) GROUP
Ortel T.L. - ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN THE THROMBOPHILIA PILOT PROJECT
Ortel T. - THROMBOSIS AND HEMOSTASIS CENTERS PILOT SITES REGISTRY: MATERNAL THROMBOPHILIA
Ortin R. - MATRIX METALLOPROTEINASE 9 (MMP-9), THROMBIN-ANTITHROMBIN COMPLEXES (TAT) AND THE FACTOR XIII VAL34LEU POLYMORPHISM IN PATIENTS WITH SPONTANEOUS ACUTE INTRACRANIAL HEMORRHAGE
  - IGM ANTI PROTEIN S ANTIBODIES AS A RISK FACTOR OF VENOUS THROMBOSIS
Ortín J. - CAPACITY OF SOLVENT-DETERGENT TREATMENT AND NANOFILTRATION APPLIED TO FVIII/VWF AND FIX PURIFICATION PROCESSES TO ELIMINATE EMERGING VIRAL PATHOGENS
Ortiz J. - NEUTRALIZATION BY AVIDIN OF ANTICOAGULANT ACTIVITY OF BIOTINYLATED IDRAPARINUX, THE FIRST AND UNIQUE REVERSIBLE LONG-ACTING ANTICOAGULANT
  - BIOEQUIPOTENCY OF IDRAPARINUX AND BIOTINYLATED IDRAPARINUX AFTER SINGLE DOSE IN HEALTHY SUBJECTS
Ortiz M. - BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS
Ortuño F. - JAK2 V617F MUTATION IS ASSOCIATED WITH THE LEUKOCYTE COUNT AND BONE MARROW CD34+ CELLS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
Osadchenko I.A. - MODULATION OF NITRIC OXIDE PRODUCTION BY CULTURED ENDOTHELIAL CELLS
  - NEUROPROTECTIVE EFFECTS OF QUERCETIN IN A GERBIL MODEL OF CEREBRAL ISCHEMIA
Osanto S. - CIRCULATING MICROPARTICLE (MP)-ASSOCIATED TISSUE FACTOR (TF) ACTIVITY AND THROMBOSIS IN CANCER PATIENTS
O'Shaughnessy D. - VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY
Osipenko A.N. - IMAGE ANALYSIS OF LYMPHOCYTES CHROMATIN AT THE APOPTOSIS
Oskolkova O. - THROMBOGENICITY OF MICROPARTICLES DERIVED FROM VASCULAR CELLS
  - REGULATION OF PROTEIN C INHIBITOR (PCI) ACTIVITY BY OXIDIZED AND NEGATIVELY CHARGED PHOSPHOLIPIDS
Osman H. - ASSESSMENT OF THE PREDICTIVE VALUE OF PFA-100 TM OCCLUSION TIME CONCERNING THE HAEMORRHAGIC RISK OF TRANSPARIETAL NEEDLE LIVER BIOPSY IN CHILDREN
Osman M. - PLASMA S/R RATIO OF WARFARIN CO-VARIES WITH VKORC1 HAPLOTYPE
Osman A. - THE PLASMA SAMPLE DILUTION IMPROVES THE CORRELATION BETWEEN REAGENTS FOR PT-METHODS
Östenson C. - INCREASED PLATELET PROCOAGULANT ACTIVITY IN TYPE 2 DIABETIC PATIENTS: INHIBITION BY GPIIB/IIIA BLOCKADE
Ostenstad B. - ACTIVATED COAGULATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Østergaard O. - STRATEGIES FOR CHARACTERIZING THE PHOSPHO- AND GLYCOPROTEOMES OF MICROPARTICLES DERIVED FROM INTERLEUKIN-1BETA STIMULATED PANCREATIC BETA-CELLS
Ostergaard H. - DEVELOPMENT OF LONG-ACTING FVIIA DERIVATIVES BY GLYCOPEGYLATION
Østergaard H. - FACTOR VIII A2 DOMAIN INTERACTION WITH LRP: IN VITRO AND IN VIVO ANALYSES
Ostergaard H. - COAGULATION FACTOR VIIA VARIANTS WITH REDUCED SUSCEPTIBILITY TO INHIBITION BY ANTITHROMBIN III
  - IMPROVING THE PHARMACOKINETICS OF RECOMBINANT FACTOR VIIA CYS407 BY CYSTEINE-DIRECTED PEGYLATION
Ostermann H. - PHARMACOKINETICS OF A PROTHROMBIN COMPLEX CONCENTRATE IN HEALTHY VOLUNTEERS
Østerud B. - BLOOD BORNE TISSUE FACTOR: CELLULAR LOCALIZATION AND SPECIFIC ACTIVITIES
  - DETERMINATION OF TISSUE FACTOR ORIGIN USING SIRNA KNOCKDOWN APPROACH IN HUMAN PERIPHERAL BLOOD WHITE CELLS
Osto E. - LOW-INTENSITY (INR TARGET 1,8) VERSUS STANDARD ANTICOAGULATION FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION: A RANDOMIZED SINGLE CENTRE STUDY IN ELDERLY PATIENTS
O'Sullivan B.P. - CYSTIC FIBROSIS HETEROZYGOTES DO NOT HAVE INCREASED PLATELET ACTIVATION
Otaki M. - CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE
  - CHARACTERIZATION OF A LARGE DELETION THAT LEADS TO CONGENITAL FACTOR XIII DEFICIENCY
  - ANALYSIS OF DISCREPANT ASSAY-DETERMINED ACTIVITY LEVELS OF FACTOR VIII ASSOCIATED WITH R531H MUTATION
Otegui M. - CAPACITY OF SOLVENT-DETERGENT TREATMENT AND NANOFILTRATION APPLIED TO FVIII/VWF AND FIX PURIFICATION PROCESSES TO ELIMINATE EMERGING VIRAL PATHOGENS
Othman M. - THE INFLUENCE OF INTRON 1 SEQUENCE VARIATIONS IN MUTATION- NEGATIVE TYPE 1 VON WILLEBRAND DISEASE PATIENTS
  - THE SPLENIC MICRO-ENVIRONMENT AND FVIII-VWF INTERACTION ARE DETERMINANTS OF THE IMMUNOGENIC PRESENTATION OF FVIII BY DENDRITIC CELLS
  - ENHANCED TOLEROGENIC PRESENTATION OF FVIII BY ANDROGRAPHOLIDE-TREATED IMMATURE DENDRITIC CELLS
  - PLATELET TYPE VON WILLEBRAND DISEASE: AN UNDERDIAGNOSED CAUSE OF EXCESSIVE MUCOCUTANEOUS BLEEDING
  - IMMUNOGLOBULIN ISOTYPES AND FUNCTIONAL ANTI-FVIII ANTIBODIES IN RESPONSE TO FVIII TREATMENT IN TWO STRAINS OF HEMOPHILIA A MICE
  - EXERCISE IMPROVES THE GLOBAL HEMOSTATIC EFFICACY IN SEVERE HEMOPHILIA A DOGS, AS DETERMINED BY THROMBELASTOGRAPHY
Otten H. - SCREENING FOR OCCULT MALIGNANCY IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOEMBOLISM. THE TROUSSEAU INVESTIGATORS
Otterdal K. - ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION
Otzen D.E. - LATE BREAKING CLINICAL TRIALS- BIOPHYSICAL INVESTIGATION OF A CONFORMATIONAL DISEASE: ANTITHROMBIN III AALBORG
Ou Y.J. - ELEVATED PLASMA FREE FATTY ACID LEVEL (MYRISTIC ACID, PALMITIC ACID, STEARIC ACID) IN TYPE 2 DIABETIC INDIVIDUAL
Oudard S. - ARE VASCULAR ENDOTHELIAL GROWTH FACTOR PLASMA LEVELS A PREDICTIVE MARKER OF SUNITINIB RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA?
  - PLATELET MICROPARTICLES ARE A PREDICTIVE FACTOR OF OVERALL SURVIVAL IN PATIENTS WITH PROSTATE CANCER
oude Egbrink M.G.A. - VISUALIZATION OF THROMBUS FORMATION ON ACUTELY RUPTURED PLAQUES IN VIVO
Oudega R. - A DIAGNOSTIC TOOL TO SAFELY EXCLUDE DVT IN HIGH RISK GROUPS
  - A DIAGNOSTIC TOOL TO SAFELY EXCLUDE DVT IN PRIMARY CARE: A VALIDATION STUDY
Oudemans-van Straaten H.M. - COAGULATION PARAMETERS OF THE ISTH OVERT DIC SCORE: FIRST, THEIR DISTRIBUTION
Oury C. - P2X1 RECEPTORS AS NEW REGULATORS OF NEUTROPHIL LIFE SPAN
  - ATP VIA P2X7 MODULATES THE TLR-DEPENDENT EXPRESSION AND ACTIVITY OF HUMAN NEUTROPHIL INFLAMMASOME
Outin H. - FIBRIN MONOMER BY A QUANTITATIVE ASSAY IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
Ouviña S.M. - COMPARISON BETWEEN CONVENTIONAL AND AUTOMATED METHODS OF RISTOCETIN COFACTOR ACTIVITY AND VON WILLEBRAND FACTOR ANTIGEN
Ouviña S. - TREATMENT WITH RECOMBINANT ACTIVATED FVII DECREASES FVIII INHIBITOR TITLE
Ouwehand W.H. - INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS
  - MONOCYTE RESPONSE TO ACTIVATED PLATELETS: A TRANSCRIPTIONAL STUDY
  - PROTEOMIC ANALYSIS OF PLATELET DETERGENT-RESISTANT MEMBRANES FROM HEALTHY HUMAN DONORS WITH "EXTREME-END" RESPONSES TO COLLAGEN-RELATED PEPTIDE AND ADP
  - RECOMBINANT HUMAN HPA-1A ANTIBODIES FOR TREATMENT OF FETO-MATERNAL ALLO-IMMUNE THROMBOCYTOPENIA (FMAIT): PROOF OF PRINCIPLE IN AN IN VIVO MURINE MODEL
  - A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP
  - ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES
  - USE OF HAEMOPHILIA A ZEBRAFISH FOR SENSITIVE SCREENING AND CHARACTERISATION OF NOVEL PLATELET CANDIDATE GENES DERIVED FROM POST-GENOME STUDIES FOR PRO-THROMBOTIC FUNCTION
  - DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME
  - NOVEL PLATELET TRANSMEMBRANE PROTEINS: IDENTIFICATION AND ANALYSIS
  - GPVI IN THE PLASMA OF HEALTHY INDIVIDUALS AND PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP), MEASURED BY A NOVEL ENZYME-LINKED IMMUNOSORBANT ASSAY
  - REGULATION OF THE PLATELET PROCOAGULANT RESPONSE
  - PLATELET GENOMICS AND THE RISK OF ARTHEROTHROMBOSIS
Ouwhand W.H. - THE EFFECT OF APHERESIS ON DONORS' PLATELETS
Ovanesov M. - WALL CLOT GROWTH IN PLASMA: EFFECT OF HIGH DOSES RECOMBINANT FVIIA
Overvad K. - EPIDEMIOLOGICAL STUDY OF VENOUS THROMBOEMBOLISM IN A BIG DANISH COHORT
Ovlisen K. - NEEDLE INDUCED HAEMARTHROSIS: A MURINE MODEL OF HEMOPHILIC SYNOVITIS
Owen W.G. - VON WILLEBRAND FACTOR (VWF) MULTIMER ANALYSIS BY IN-GEL IMMUNOSTAINING AND INFRARED IMAGING
Owen J. - HEPARIN-INDUCED PLATELET AGGREGATION DOES NOT PREDICT THE PRESENCE OF ANTI-HEPARIN ANTIBODIES
Owen W.G. - A HIGHLY-SENSITIVE PLASMA VON WILLEBRAND FACTOR (VWF):RISTOCETIN COFACTOR ACTIVITY ASSAY BY FLOW CYTOMETRY
Owen J. - A NEW ADAMTS13 ACTIVITY ASSAY USED WITH ANTIGEN ASSAY PROVIDES DIAGNOSTIC INFORMATION IN TTP, BLEEDING OR THROMBOSIS
Owens S. - BASELINE QUALTIY OF LIFE (QOL) IN HEMOPHILIA PATIENTS RECEIVING CARE AT U.S. CENTERS
Owings J.T. - COMPARISON OF PRE-TEST PROBABILITY SCORES TO COMMERCIAL ASSAYS FOR MEASURING ANTIBODIES ASSOCIATED WITH HEPARIN-INDUCED THROMBOCYTOPENIA
  - LOW-DOSE (1.2MG) RFVIIA TO REVERSE WARFARIN THERAPY IN CRITICALLY ILL PATIENTS WITH MAJOR BLEEDING
  - EVALUATION OF A PROTOTYPE MULTIPLEX METHOD FOR EVALUATING PHOSPHOLIPID ANTIBODIES
Owings J. - EXPLORING ADULT PATIENT POPULATIONS AT RISK FOR DEVELOPING HIT
Oyama Y. - HMGB1 PLAYS A CENTRAL ROLE IN ATHEROTHROMBOSIS
Oyen F. - A COMMON LARGE DELETION OF VWF IN GERMAN AND ITALIAN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE TYPE 3
Oz E. - DNA REPAIR GENE XRCC1 AND XPD POLYMORPHISMS AND THEIR ASSOCIATION WITH CORONARY ARTERY DISEASE RISKS AND MICRONUCLEUS FREQUENCY
Ozaki Y. - CLEC-2, A NOVEL PLATELET ACTIVATION RECEPTOR, IS INVOLVED IN PODOPLANIN-MEDIATED PLATELET ACTIVATION BY CANCER CELLS
  - PLATELET ADHESION TO LAMININ IS MEDIATED THROUGH VON WILLEBRAND FACTOR AND GLYCOPROTEIN IB UNDER HIGH SHEAR FLOW
Ozaki M. - TRANSFUSION OF FRESH FROZEN PLASMA AND PLATELETS TO ACHIEVE HEMOSTASIS DURING CARDIOVASCULAR SURGERY INCREASES THE RISK OF POSTOPERATIVE INFECTION
Ozaki Y. - A ROLE FOR GEMS IN PLATELET GLYCOPROTEIN IB-MEDIATED PLATELET ACTIVATION
  - SYNERGISM BETWEEN GI ACTIVATION AND CA2+ MOBILIZATION IN PLATELET THROMBOXANE A2 FORMATION
  - THE PLATELET ACTIVATION C-TYPE LECTIN RECEPTOR CLEC-2 SIGNALS VIA A NOVEL YXXL DEPENDENT SIGNALLING CASCADE DISTINCT FROM THAT OF ITAM RECEPTORS
  - G PROTEIN-COUPLED RECEPTOR KINASE-INTERACTING PROTEIN1 (GIT1) IS TYROSINE-PHOSPHORYLATED DOWNSTREAM OF INTEGRIN ALPHA IIB BETA3 IN PLATELETS
  - EXTRACTS OF AN EDIBLE MUSHROOM WITH ANTITHROMBIN III-INDEPENDENT ANTICOAGULANT ACTIVITY
Ozaydin A. - DNA REPAIR GENE XRCC1 AND XPD POLYMORPHISMS AND THEIR ASSOCIATION WITH CORONARY ARTERY DISEASE RISKS AND MICRONUCLEUS FREQUENCY
Ozcan M. - THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS
Ozek E. - RECOMBINANT FVIIA USE IN THREE PRETERM NEONATES WITH DISSEMINATED INTRAVASCULAR COAGULATION
Ozelo M.C. - SIMULTANEOUS BLEEDING AND THROMBOSIS AS THE INITIAL PRESENTATION OF SUPERWARFARIN POISONING
Ozelo M. - SAFE AND LONG-TERM EXPRESSION OF FVIII FOLLOWING SUBCUTANEOUS IMPLANTATION OF GENETICALLY-MODIFIED ENDOTHELIAL PROGENITORS IN HEMOPHILIA A MICE
Ozelo M.C. - DAPSONE TREATMENT IN STEROID-DEPENDENT OR REFRACTORY ADULT ITP PATIENTS CAN AVOID IMMEDIATE SPLENECTOMY AFTER STEROID FAILURE
  - MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF FVIII MUTATIONS IN A FEMALE WITH SEVERE HEMOPHILIA A
Ozenne G. - HAEMOSTASIS DISTURBANCES IN TYPE I AND II DIABETES MELLITUS
Ozier Y. - THE COAGULOPATHY OF MASSIVE TRANSFUSION
Ozlen B. - THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL
Ozsan H. - THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS
Ozulker T. - RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY
Ozyurek H. - CEREBRAL THROMBOSIS ASSOCIATED WITH HETEROZYGOUS FV LEIDEN MUTATION AND HIGH LIPOPROTEIN A LEVEL IN A GIRL WITH FACTOR XIII DEFICIENCY